Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow.
Atherosclerosis develops in distinct regions of the arterial tree. Defining patterns and mechanisms of endothelial cell gene expression in different regions of normal arteries is key to understanding the initial molecular events in atherogenesis. In this study, we demonstrated that the expression of endothelial nitric-oxide synthase (eNOS), an atheroprotective gene, and its phosphorylation on Ser(1177), a marker of activity, were lower in regions of the normal mouse aorta that are predisposed to atherosclerosis. The same expression pattern was observed in mouse strains that are both susceptible and resistant to atherosclerosis, and the topography of eNOS expression was inverse to p65, the main nuclear factor-kappaB subunit. Modeling of disturbed and uniform laminar flow in vitro reproduced the expression patterns of eNOS and p65 that were found in vivo. Heterogeneous nuclear RNA expression and RNA polymerase II chromosome immunoprecipitation studies demonstrated that regulation of transcription contributed to increased eNOS expression in response to shear stress. In vivo, the transcription of eNOS was reduced in regions of the mouse aorta predisposed to atherosclerosis, as defined by reporter gene expression in eNOS promoter-beta-galactosidase reporter transgenic mice. These data suggest that disturbed hemodynamic patterns found at arterial branches and curvatures uniquely modulate endothelial cell gene expression by regulating transcription, potentially explaining why these regions preferentially develop atherosclerosis when risk factors such as hypercholesterolemia are introduced.
Won
Doyon
D
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Zhu
Su-Ning
SN
Chen
Mian
M
Teichert
Anouk-Martine
AM
Fish
Jason E
JE
Matouk
Charles C
CC
Bonert
Michael
M
Ojha
Matadial
M
Marsden
Philip A
PA
Cybulsky
Myron I
MI
D000818:Animals; D001011:Aorta / Q000201:enzymology; D050197:Atherosclerosis / Q000201:enzymology* / Q000235:genetics; D001916:Brachial Artery / Q000201:enzymology; D004730:Endothelium, Vascular / Q000201:enzymology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D052247:Nitric Oxide Synthase Type II / Q000096:biosynthesis* / Q000235:genetics; D052250:Nitric Oxide Synthase Type III; D010766:Phosphorylation; D012333:RNA, Messenger / Q000378:metabolism; D012039:Regional Blood Flow; D033081:Shear Strength; D013552:Swine; D051996:Transcription Factor RelA / Q000378:metabolism; D014158:Transcription, Genetic
D012333:RNA, Messenger; C498144:Rela protein, mouse; D051996:Transcription Factor RelA; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; C496315:Nos3 protein, mouse